TNKase, Metalyse (tenecteplase) is an enzyme pharmaceutical. Tenecteplase was first approved as TNKase on 2000-06-02. It is used to treat coronary thrombosis and myocardial infarction in the USA. It has been approved in Europe to treat myocardial infarction.
|Indication||coronary thrombosis, myocardial infarction|
|Drug Class||Enzymes: tissue-type plasminogen activators|